AMCLX
AMCLX operates in various business sectors.
Market Cap & Net Worth: AMCLX (AMCLX)
AMCLX (NMFQS:AMCLX) has a market capitalization of $90.97K ($90.97K) as of March 19, 2026. Listed on the NMFQS stock exchange, this USA-based company holds position #41394 globally and #13462 in its home market, demonstrating a -2.34% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying AMCLX's stock price $9.18 by its total outstanding shares 9910 (9.91K).
AMCLX Market Cap History: 2021 to 2025
AMCLX's market capitalization history from 2021 to 2025. Data shows growth from $79.31K to $90.97K (4.27% CAGR).
AMCLX Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how AMCLX's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of AMCLX by Market Capitalization
Companies near AMCLX in the global market cap rankings as of March 19, 2026.
Key companies related to AMCLX by market ranking:
- Renewi PLC (LSE:RWI): Ranked #41385 globally with a market cap of $85.13K USD ( GBX699.70 Million GBX).
- Scandion Oncology A/S (ST:SCOL): Ranked #41386 globally with a market cap of $85.13K USD ( Skr954.98K SEK).
- Stellus Capital Investment (NYSE:SCM): Ranked #41395 globally with a market cap of $84.65K USD.
- ZWIPE AS NK -10 (F:4ZW): Ranked #41396 globally with a market cap of $84.59K USD ( €82.40K EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #41385 | Renewi PLC | LSE:RWI | $85.13K | GBX868.00 |
| #41386 | Scandion Oncology A/S | ST:SCOL | $85.13K | Skr0.00 |
| #41395 | Stellus Capital Investment | NYSE:SCM | $84.65K | $9.14 |
| #41396 | ZWIPE AS NK -10 | F:4ZW | $84.59K | €0.00 |
AMCLX Historical Marketcap From 2021 to 2025
Between 2021 and today, AMCLX's market cap moved from $79.31K to $ 90.97K, with a yearly change of 4.27%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $90.97K | -5.26% |
| 2024 | $96.03K | +8.56% |
| 2023 | $88.46K | +8.44% |
| 2022 | $81.57K | +2.85% |
| 2021 | $79.31K | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of AMCLX was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $90.97K USD |
| MoneyControl | $90.97K USD |
| MarketWatch | $90.97K USD |
| marketcap.company | $90.97K USD |
| Reuters | $90.97K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.